Health

InxMed Presents New Data at 14th Annual World ADC Highlighting Synergy of IN10018 with ADCs and Novel Stroma targeting pipeline

NANJING, China, Oct. 18, 2023 /PRNewswire/ -- InxMed Co., Ltd, a clinical-stage biotechnology company dedicated on developing innovative therapies to overcome treatment resistance for hard-to-treat solid tumors, is presenting preclinical data at 14th Annual World ADC Conference in San Diego regar...

2023-10-19 08:00 1495

Zepp Health Sponsors Cal Hacks 10.0, the World's Largest Collegiate Hackathon, for the Second Consecutive Year

- Winners with the best apps will receive Zepp's Amazfit smartwatches and cash award MILPITAS, Calif., Oct. 18, 2023 /PRNewswire/ -- Zepp Health Corporation, a global leader in smart wearables and health technology, is excited to announce its sponsorship of Cal Hacks, the world's largest collegi...

2023-10-19 03:04 1724

ITRI Excels with Eight 2023 R&D 100 Awards, Showcasing Biotechnological Triumph

HSINCHU, Oct. 18, 2023 /PRNewswire/ -- In the recent announcement of the 2023 R&D 100 Awards,ITRI , Taiwan's largest and one of the world's leading high-tech applied research institutions, has clinched eight 2023 R&D 100 Awards, the second-highest number of awards by a s...

2023-10-19 01:10 1873

CJ Foods Partners with T&R Biofab to Shape the Future of Food

CJ Foods and T&R Biofab aim to synergize their unique expertise and technologies to bring to the market innovative food products SEOUL, South Korea, Oct. 18, 2023 /PRNewswire/ -- CJ Foods, a business unit of South Korea-based CJ CheilJedang, announced that it entered into a joint development agre...

2023-10-18 21:00 1901

Complete Genomics Partners with Integrated DNA Technologies to Establish New Ecosystem of NGS Products

SAN JOSE, California, Oct. 18, 2023 /PRNewswire/ -- Complete Genomics, Inc., a pioneering genomic sequencing company, today announced its partnership with Integrated DNA Technologies (IDT), a global genomics solutions provider, to develop an ecosystem of advanced com...

2023-10-18 20:00 1481

SK pharmteco to showcase its extensive APIs and CGT capabilities in CPHI 2023

* With a dedicated booth in the main exhibition hall, SK pharmteco solidifies its global position as the most trusted CDMO partner in the pharmaceutical industry * Appoints Chief Commercial Officer Andrew Fenny to strengthen its global marketing capabilities * Shortlisted as a finalist for ...

2023-10-18 20:00 1335

Origin Agritech Chairman Dr. Gengchen Han to Participate at the 2023 Asia-Pacific Agri-Food Innovation Summit

BEIJING, Oct. 18, 2023 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, today announced that Dr. Gengchen Han, Chairman and Chief Executive Officer of Origin Agritech, will participate in a panel discussion onThe R...

2023-10-18 19:30 1674

Ando Foundation and Nissin Food Products Release "Recipes for Wellbeing Report": First Global Study Reveals Direct Correlation Between Food and Wellbeing

OSAKA, Japan, Oct. 18, 2023 /PRNewswire/ -- The Ando Foundation (*) (hereinafter "the Foundation") and Nissin Food Products Co., Ltd. (hereinafter "the Company") released the Recipes for Wellbeing Report onOctober 18, 2023, in cooperation with global analytics and advice firm Gallup, the first gl...

2023-10-18 16:00 1686

WuXi XDC and HKSTP Join Forces to Promote Development of Bioconjugate Drug Industry in Hong Kong

* Hong Kong Science and Technology Parks Corporation (HKSTPC) and WuXi XDC signed a cooperation framework agreement to jointly promote the establishment of a contract research, development and manufacturing organization(CRDMO) value chain inHong Kong. * HKSTP Park companies will leverage WuXi...

2023-10-18 11:00 1460

First Patient Dosed in the Registrational Phase III Study of Olverembatinib in Treatment-Naïve Patients with Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)

SUZHOU, China and ROCKVILLE, Md., Oct. 17, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that the registrational Phase III study (HQP1351AG...

2023-10-18 10:11 1435

Ubie's new Generative AI feature for doctors effortlessly summarizes patient findings and streamlines medical record documentation with a 90% User Satisfaction rate.

NEW YORK, Oct. 17, 2023 /PRNewswire/ -- Ubie , Inc. (Headquartered in Chuo-ku,Tokyo, Co-Representative Directors: Yoshinori Abe & Kota Kubo, referred to as 'Ubie') released a new feature utilizing generative AI (LLM: Large Language Model) for doctors to generate AI...

2023-10-17 23:00 1832

Congratulations to Sanyou Bio for achieving ISO9001 & IPMS certifications

SHANGHAI, Oct. 17, 2023 /PRNewswire/ -- Sanyou Biopharmaceuticals Co., Ltd is pleased to announce inOctober 2023, we have obtained ISO 9001 and IPMS certifications. These certifications emphasize Sanyou's commitment to consistency, reliability, and accountability in our innovative biopharmaceuti...

2023-10-17 21:00 1449

Global Healthcare Startup Sky Labs Attracts Investments Totaling KRW 20.7 Billion in a Series C Round

- Major investors include Korea Development Bank (KDB), K2 Investment Partners, DEVSISTERS VENTURES, SJG Partners, and OPENWATER INVESTMENT - Distribution of 'CART BP,' a ring-type cuffless blood pressure monitor that enables continuous blood pressure measurement and monitoring 24/7, will be ful...

2023-10-17 20:00 1563

WuXi Biologics Launches New High-Productivity Bioprocessing Platform WuXiUI™ for Cost-Effective Commercial Manufacturing and Desirable Product Quality

* WuXiUI™ ultra-intensified fed-batch platform offers a new process option for maximum flexibility to meet various clients' needs in biologics development and manufacture. The platform can significantly improve productivity and quality, and reduce cost-of-goods (COGS) in commercial manufacturin...

2023-10-17 08:30 1555

CANbridge Announces NDA Acceptance of CAN108 (邁芮倍®/LIVMARLI®) for Cholestatic Pruritus in Progressive Familial Intrahepatic Cholestasis (PFIC) by China's National Medical Products Administration

BEIJING and BURLINGTON, Mass., Oct. 16, 2023 /PRNewswire/ -- CANbridge Pharmaceuticals Inc. (HKEX:1228), a global biopharmaceutical company, with a foundation inChina,  committed to the research, development and commercialization of transformative rare disease and rare oncology therapies, announ...

2023-10-17 08:00 9185

Chamlion Partners with GPAINNOVA to Accelerate the Digitization of Dental Industry

SHANGHAI, Oct. 16, 2023 /PRNewswire/ -- On October 15th, Chamlion and global surface metal finishing expert GPAINNOVA signed a strategic cooperation agreement. Chamlion will become GPAINNOVA's exclusive dental strategic partner inChina. The two companies will establish a joint venture in China to...

2023-10-16 22:27 1428

Abbisko will debut two blockbuster clinical research results at the 2023 European Society for Medical Oncology(ESMO)

SHANGHAI, Oct. 16, 2023 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter) announced that the clinical results of first-in-human study of FGFR4 inhibitor Irpagratinib(ABSK011)and the clinical results of first-in-human dose-escalating of PD-L1 inhibitor ABSK043 with...

2023-10-16 21:50 1697

New Study Demonstrates Lunit SCOPE IO's Effectiveness to Predict Biliary Tract Cancer Therapy Outcomes - Findings to be Presented at the ESMO 2023

- Nine abstracts, featuring the effectiveness of Lunit's AI-powered TIL/WSI analyzer and biomarker platform, accepted by the ESMO 2023 Congress SEOUL, South Korea, Oct. 16, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeut...

2023-10-16 21:10 1513

TaiMed Announces Significant Progress in Clinical Trials for New HIV Treatment

Company champions long-acting HIV therapy with new biologic drug TMB-365/380 combination; after favorable results of Phase1b/2a, company plans to accelerate Phase 2 clincial study to expedite path to market TAIPEI, Oct. 16, 2023 /PRNewswire/ -- TaiMed Biologics

2023-10-16 21:00 1373

SeekIn Presents New Validation Studies of OncoSeek Multi-cancer Early Detection test at Early Detection of Cancer Conference in London

Two Sample Types, Three Different Platforms, Five Independent Cohorts of ~10,000 Cancer Patients and Non-cancer Individuals with Diverse Ethnic Backgrounds Validate OncoSeek's Ability to Detect Multiple Cancer Types and Predict Tissue of Origin of Cancers SHENZHEN, China, Oct. 16, 2023 /PRNewswi...

2023-10-16 20:00 1361
1 ... 57585960616263 ... 272